Lithium is greatest at reducing the chance of depression-related hospitalisation in bipolar dysfunction, based on new cohort research
Stopping depressive relapse is a serious purpose within the administration of bipolar dysfunction. It has been proven that despair makes up round 72% of general time spent sick in individuals with bipolar (Forte et al., 2015), and that bipolar despair particularly is related to important bodily and psychological morbidity, in addition to elevated mortality (Baldessarini…